Command Palette

Search for a command to run...

Tier IIIWake-promoting142 trials

Modafinil — The Eugeroic Cognitive Enhancer

Modafinil is a prescription wake-promoting agent (eugeroic) primarily used to treat narcolepsy and shift-work sleep disorder. While it is widely used off-label as a cognitive enhancer to improve focus and executive function, its direct relevance to biological aging and longevity remains unestablished.

Mechanism of Action

Modafinil is an atypical, weak dopamine reuptake inhibitor that binds to the dopamine transporter (DAT), leading to increased extracellular dopamine. Unlike classical stimulants, it also activates the orexinergic system in the hypothalamus, which regulates wakefulness and arousal. Additionally, modafinil elevates cortical levels of histamine, norepinephrine, and glutamate while decreasing GABAergic transmission. These combined neurochemical actions promote wakefulness and enhance cognitive control without the severe autonomic stimulation or high abuse liability typical of amphetamines.

Human Trial Evidence

Modafinil has been extensively studied in humans for sleep disorders and cognitive enhancement. A 2015 systematic review found that modafinil improves executive function, attention, and learning in healthy, non-sleep-deprived individuals. However, there are no published human longevity trials evaluating its effects on lifespan or healthspan metrics.

Dosing Protocol

100–200 mg/day is the standard clinical dose, typically taken in the morning to avoid sleep disruption. In off-label cognitive enhancement, doses of 50–200 mg are common. Modafinil is a prescription-only medication (Schedule IV in the US).

Safety & Contraindications

Common adverse effects include headache, nausea, nervousness, and insomnia. It can induce rare but severe dermatological reactions, such as Stevens-Johnson syndrome. Modafinil induces the CYP3A4 enzyme, which can reduce the efficacy of oral contraceptives and other medications metabolized by this pathway. It should be used with caution in individuals with cardiovascular disease or a history of psychiatric disorders, and it carries a mild potential for dependence.

Quick Stats
Evidence TierTier III
Clinical Trials142
Typical Dose100–200 mg
Est. Cost/Day$0.62
Purity99.5%
Synergistic Compounds
CaffeineL-TheanineAlpha-GPC
Medical disclaimer: This page is for informational purposes only. Consult a qualified healthcare provider before starting any supplement regimen. Vitaei does not provide medical advice.